Lipids and lipid metabolic pathways have taken center stage as possible therapeutic targets in several neurodegenerative disease as for example Alzheimers disease, Multiple Sclerosis or ALS. At this international meeting , scientists will discuss the current stage and future developments in the field of "lipids in brain disease" with a specific focus on technologies and patho-physiological mechanisms.